Healthcare

Telerehabilitation Market To Reach USD 12.90 Bn By 2032

The telerehabilitation market size was valued at USD 3.58 billion in 2023 and is expected to reach USD 12.90 billion by 2032, growing at a CAGR of 15.30% from 2023 to 2032.

Telerehabilitation Market Size 2023 To 2032

Key Takeaways

  • North America contributed more than 41% of revenue share in 2022.
  • Asia Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
  • By component, the software segment has held the largest market share of 60% in 2022.
  • By component, the hardware segment is anticipated to grow at a remarkable CAGR of 18.4% between 2023 and 2032.
  • By service, the clinical therapy segment generated over 62% of revenue share in 2022.
  • By service, the clinical assessment segment is expected to expand at the fastest CAGR over the projected period.
  • By therapy, the physical therapy segment generated over 42% of revenue share in 2022.
  • By Therapy, the occupational therapy segment is expected to expand at the fastest CAGR over the projected period.

The telerehabilitation market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market

The study offers intricate dynamics about different aspects of the global telerehabilitation market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global telerehabilitation market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/3619

Telerehabilitation Market Scope

Report CoverageDetails
Growth Rate from 2023 to 2032CAGR of 15.30%
Market Size in 2023USD 3.58 Billion
Market Size by 2032USD 12.90 Billion
Largest MarketNorth America
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Component, By Services, and By Therapy
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

This study covers an elaborate segmentation of the global telerehabilitation market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global telerehabilitation market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.

Read Also: Wireless Implants Market Size To Reach USD 29.51 Bn By 2032

Recent Developments

  • In January 2019, MedRisk introduced a tele-rehabilitation element to its onsite physical therapy initiative, ensuring uniform care for injured workers, irrespective of their geographical location.
  • In January 2019, eWellness Healthcare Corporation, known for its cutting-edge PHZIO platform in the physical therapy and telehealth sectors, unveiled version 3.0 of its digital treatment platform, PHZIO. This release marked a significant upgrade, reflecting the company’s commitment to advancing its capabilities in the evolving landscape of digital healthcare and rehabilitation services.

Telerehabilitation Market Players

  • Philips Healthcare
  • Honeywell International Inc.
  • InTouch Health
  • Cisco Systems, Inc.
  • Medtronic plc
  • Tunstall Healthcare Group
  • MDLive Inc.
  • VeeMed
  • eWellness Healthcare Corporation
  • Neuro Rehab VR
  • Doctor On Demand, Inc.
  • GlobalMedia Group, LLC
  • 3D Systems, Inc.
  • Tyromotion GmbH
  • Basis Science, Inc.

Segments Covered in the Report

By Component

  • Hardware
  • Software

By Services

  • Clinical Assessment
  • Clinical Therapy

By Therapy

  • Physical Therapy
  • Occupational Therapy
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Research Methodology

The research methodology acquire by analysts for assemble the global telerehabilitation market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global telerehabilitation market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Telerehabilitation Market 

5.1. COVID-19 Landscape: Telerehabilitation Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Telerehabilitation Market, By Component

8.1. Telerehabilitation Market, by Component, 2023-2032

8.1.1 Hardware

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Software

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Telerehabilitation Market, By Services

9.1. Telerehabilitation Market, by Services, 2023-2032

9.1.1. Clinical Assessment

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Clinical Therapy

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Telerehabilitation Market, By Therapy 

10.1. Telerehabilitation Market, by Therapy, 2023-2032

10.1.1. Physical Therapy

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Occupational Therapy

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Others

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Telerehabilitation Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Component (2020-2032)

11.1.2. Market Revenue and Forecast, by Services (2020-2032)

11.1.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Services (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Services (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Component (2020-2032)

11.2.2. Market Revenue and Forecast, by Services (2020-2032)

11.2.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Services (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Services (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Component (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Services (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Component (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Services (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Component (2020-2032)

11.3.2. Market Revenue and Forecast, by Services (2020-2032)

11.3.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Services (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Services (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Component (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Services (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Component (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Services (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.4.2. Market Revenue and Forecast, by Services (2020-2032)

11.4.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Services (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Services (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Component (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Services (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Component (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Services (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.5.2. Market Revenue and Forecast, by Services (2020-2032)

11.5.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Component (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Services (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Therapy (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Component (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Services (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Therapy (2020-2032)

Chapter 12. Company Profiles

12.1. Philips Healthcare

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Honeywell International Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. InTouch Health

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Cisco Systems, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Medtronic plc

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Tunstall Healthcare Group

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. MDLive Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. VeeMed

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. eWellness Healthcare Corporation

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Neuro Rehab VR

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

Show More

Related Articles

Back to top button